Neogen (NEOG) Is At $59.10 Formed Wedge; Litespeed Management Has Trimmed By $11.16 Million Its Depomed Ord (DEPO) Stake

Litespeed Management Llc decreased Depomed Ord (DEPO) stake by 97.36% reported in 2017Q3 SEC filing. Litespeed Management Llc sold 2.23 million shares as Depomed Ord (DEPO)’s stock declined 38.37%. The Litespeed Management Llc holds 60,514 shares with $350,000 value, down from 2.29 million last quarter. Depomed Ord now has $438.57M valuation. The stock decreased 3.73% or $0.27 during the last trading session, reaching $6.96. About 1.34 million shares traded. Depomed, Inc. (NASDAQ:DEPO) has declined 46.86% since February 3, 2017 and is downtrending. It has underperformed by 63.56% the S&P500.

Neogen Corporation (NEOG) formed wedge down with $56.15 target or 5.00% below today’s $59.10 share price. Neogen Corporation (NEOG) has $3.05 billion valuation. The stock decreased 0.14% or $0.08 during the last trading session, reaching $59.1. About 164,584 shares traded or 17.50% up from the average. Neogen Corporation (NASDAQ:NEOG) has risen 27.20% since February 3, 2017 and is uptrending. It has outperformed by 10.50% the S&P500.

Since August 8, 2017, it had 0 buys, and 18 sales for $13.55 million activity. BRADLEY EDWARD sold $1.54 million worth of Neogen Corporation (NASDAQ:NEOG) on Thursday, September 28. The insider MORRICAL TERRI A sold $421,833. Another trade for 10,000 shares valued at $770,565 was made by HERBERT JAMES L on Friday, September 29. 4,333 shares valued at $296,772 were sold by Green Ronald D on Tuesday, August 8. Quinlan Steven J. had sold 2,250 shares worth $176,676 on Wednesday, October 4. Another trade for 6,000 shares valued at $358,320 was sold by PAPESH G BRUCE.

Investors sentiment increased to 1.48 in Q3 2017. Its up 0.43, from 1.05 in 2017Q2. It is positive, as 10 investors sold Neogen Corporation shares while 53 reduced holdings. 31 funds opened positions while 62 raised stakes. 33.03 million shares or 0.90% more from 32.73 million shares in 2017Q2 were reported. Wms Prtn Ltd Llc holds 4.25% of its portfolio in Neogen Corporation (NASDAQ:NEOG) for 461,097 shares. Piedmont Invest Advsr Limited Company has 8,321 shares for 0.01% of their portfolio. Clean Yield Grp holds 3,537 shares or 0.11% of its portfolio. Deutsche Bank Ag holds 74,025 shares or 0% of its portfolio. State Street Corporation holds 0.01% of its portfolio in Neogen Corporation (NASDAQ:NEOG) for 943,138 shares. Cookson Peirce & Incorporated has 0.04% invested in Neogen Corporation (NASDAQ:NEOG) for 5,010 shares. Loomis Sayles & Ltd Partnership owns 251,513 shares or 0.04% of their US portfolio. State Common Retirement Fund stated it has 0.08% in Neogen Corporation (NASDAQ:NEOG). Moreover, Victory Mgmt has 0% invested in Neogen Corporation (NASDAQ:NEOG). Rmb Mgmt Ltd Liability reported 0.1% in Neogen Corporation (NASDAQ:NEOG). Atlantic Trust Group Ltd Llc accumulated 49,464 shares. Zurcher Kantonalbank (Zurich Cantonalbank) has 1,242 shares. Raymond James Tru Na invested in 0.02% or 3,150 shares. California Employees Retirement invested 0.01% in Neogen Corporation (NASDAQ:NEOG). Huntington Natl Bank accumulated 1,018 shares or 0% of the stock.

Among 4 analysts covering Neogen (NASDAQ:NEOG), 0 have Buy rating, 0 Sell and 4 Hold. Therefore 0 are positive. Neogen has $80.0 highest and $62.0 lowest target. $71’s average target is 20.14% above currents $59.1 stock price. Neogen had 6 analyst reports since August 26, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Tuesday, December 22 by Craig Hallum. The company was downgraded on Wednesday, August 26 by Zacks. The stock has “Hold” rating by Zacks on Tuesday, September 22. Roth Capital maintained Neogen Corporation (NASDAQ:NEOG) rating on Thursday, January 4. Roth Capital has “Hold” rating and $62.0 target.

Among 14 analysts covering Depomed Inc (NASDAQ:DEPO), 6 have Buy rating, 2 Sell and 6 Hold. Therefore 43% are positive. Depomed Inc had 50 analyst reports since July 30, 2015 according to SRatingsIntel. The stock of Depomed, Inc. (NASDAQ:DEPO) earned “Buy” rating by TH Capital on Wednesday, November 11. The stock of Depomed, Inc. (NASDAQ:DEPO) has “Sector Perform” rating given on Tuesday, February 23 by RBC Capital Markets. The company was downgraded on Tuesday, August 8 by Morgan Stanley. Mizuho initiated the stock with “Neutral” rating in Thursday, January 7 report. Mizuho maintained Depomed, Inc. (NASDAQ:DEPO) on Wednesday, October 11 with “Hold” rating. As per Friday, November 10, the company rating was maintained by UBS. The firm earned “Hold” rating on Thursday, September 14 by RBC Capital Markets. The stock of Depomed, Inc. (NASDAQ:DEPO) earned “Underweight” rating by Piper Jaffray on Monday, December 12. As per Monday, May 9, the company rating was upgraded by Mizuho. The firm earned “Hold” rating on Friday, October 27 by RBC Capital Markets.

Analysts await Depomed, Inc. (NASDAQ:DEPO) to report earnings on February, 20. They expect $-0.22 EPS, up 69.44% or $0.50 from last year’s $-0.72 per share. After $-0.25 actual EPS reported by Depomed, Inc. for the previous quarter, Wall Street now forecasts -12.00% EPS growth.

Since December 14, 2017, it had 1 buying transaction, and 0 selling transactions for $612,000 activity. The insider HIGGINS ARTHUR J bought 75,000 shares worth $612,000.